UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis

Osteoporosis international, 2019-07, Vol.30 (7), p.1465-1473

2019

Volltextzugriff (PDF)

Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population

Journal of medical economics, 2024-12, Vol.27 (1), p.1300-1307

2024

Volltextzugriff (PDF)

AB1129 Hyper Immunoglobulin D Syndrome (HIDS): Understanding What it is Like to Live with this Rare Condition

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1279-1279

2015

Volltextzugriff (PDF)

AB1131 Living with Tumour Necrosis Factor Receptor-Associated Periodic Fever Syndrome (TRAPS)

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1280-1280

2015

Volltextzugriff (PDF)

Efficacy of telaprevir and boceprevir in treatment-naïve and treatment-experienced genotype 1 chronic hepatitis C patients: an indirect comparison using Bayesian network meta-analysis

Current medical research and opinion, 2012-11, Vol.28 (11), p.1841-1856

2012

Volltextzugriff (PDF)

Living with Tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS)

Pediatric rheumatology online journal, 2015-09, Vol.13 (Suppl 1), p.P23-P23, Article P23

2015

Volltextzugriff (PDF)

Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting

Value in health, 2014-11, Vol.17 (7), p.A367-A367

2014

Volltextzugriff (PDF)

Different Discounting Approaches and Their Impact in Economic Evaluation: A Practical Example Using Hepatitis B Vaccination

Value in health, 2013-11, Vol.16 (7), p.A355-A356

2013

Volltextzugriff (PDF)

Long-Term Costs and Survival Associated with Immunosuppressant Following Liver Transplantation: A Markov Model

Value in health, 2013-11, Vol.16 (7), p.A633-A633

2013

Volltextzugriff (PDF)

P33 Inflation Reduction Act Data Collection Provisions

Value in health, 2024-06, Vol.27 (6), p.S8-S8

2024

Volltextzugriff (PDF)

POSB223 Impact of the COVID-19 Pandemic on Influenza Vaccination Policies

Value in health, 2022-01, Vol.25 (1), p.S147-S147

2022

Volltextzugriff (PDF)

PIN45 The Challenges of Estimating the Comprehensive Dengue Economic Burden

Value in health, 2020-12, Vol.23, p.S552-S552

2020

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of a Vaccination Programme for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia in Adults Aged 50 and Over in Germany

Value in health, 2013-11, Vol.16 (7), p.A383-A383

2013

Volltextzugriff (PDF)

RWD111 Influenza Vaccine Sales During the COVID-19 Era

Value in health, 2022-12, Vol.25 (12), p.S470-S470

2022

Volltextzugriff (PDF)

EPH185 Increased Influenza Vaccine Coverage Rate Following COVID-19: Durable Trend or Epiphenomenon?

Value in health, 2022-12, Vol.25 (12), p.S226-S226

2022

Volltextzugriff (PDF)

HPR202 Use of Real-World Data in Regulatory and Reimbursement Submissions for Personalized Medicines in Europe

Value in health, 2022-12, Vol.25 (12), p.S270-S270

2022

Volltextzugriff (PDF)

HTA205 Time to Reimbursement Decisions for Personalized Medicines in the UK and France

Value in health, 2022-12, Vol.25 (12), p.S337-S337

2022

Volltextzugriff (PDF)

POSC198 Impact of COVID-19 on Influenza Vaccine Coverage Rate During the 2020/2021 Season

Value in health, 2022-01, Vol.25 (1), p.S139-S140

2022

Volltextzugriff (PDF)

POSB192 Public Health and Economic Impact of Influenza Immunization by Pharmacists: A Systematic Literature Review and Analysis of the French Experience

Value in health, 2022-01, Vol.25 (1), p.S132-S132

2022

Volltextzugriff (PDF)

PIN56 Economic Value of Telaprevir for the Treatment of Previously Untreated F2 Fibrosis Chronic Hepatitis C Patients

Value in health, 2012-11, Vol.15 (7), p.A395-A395

2012

Volltextzugriff (PDF)

PIN4 Mixed-Treatment Comparison of the Efficacy and Safety of Antiretroviral Drugs Indicated for Treatment-Experienced HIV Patients

Value in health, 2012-11, Vol.15 (7), p.A385-A385

2012

Volltextzugriff (PDF)

1088 IMPACT OF SUSTAINED VIROLOGICAL RESPONSE (SVR) ON LIFE EXPECTANCY AND QUALITY-ADJUSTED LIFE-YEARS (QALYS) IN CHRONIC HEPATITIS C (CHC) PATIENTS

Journal of hepatology, 2010, Vol.52, p.S421-S421

2010

Volltextzugriff (PDF)

9081 POSTER Network Meta-analysis of Second and Third-line Treatments on Overall Response and Overall Survival in Patients With Metastatic Non-small Cell Lung Cancer

European journal of cancer (1990), 2011, Vol.47, p.S616-S617

2011

Volltextzugriff (PDF)

PIN79 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Population

Value in health, 2020-12, Vol.23, p.S558-S558

2020

Volltextzugriff (PDF)

PIN107 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Elderly Population

Value in health, 2020-12, Vol.23, p.S561-S561

2020

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(59)
Webseiten
(2)

Sprache

Englisch
(60)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis

Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population

AB1129 Hyper Immunoglobulin D Syndrome (HIDS): Understanding What it is Like to Live with this Rare Condition

AB1131 Living with Tumour Necrosis Factor Receptor-Associated Periodic Fever Syndrome (TRAPS)

Efficacy of telaprevir and boceprevir in treatment-naïve and treatment-experienced genotype 1 chronic hepatitis C patients: an indirect comparison using Bayesian network meta-analysis

Living with Tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS)

Cost-Effectiveness Of Everolimus Plus Reduced Tacrolimus In De Novo Liver-Recipients In The Italian Setting

Different Discounting Approaches and Their Impact in Economic Evaluation: A Practical Example Using Hepatitis B Vaccination

Long-Term Costs and Survival Associated with Immunosuppressant Following Liver Transplantation: A Markov Model

P33 Inflation Reduction Act Data Collection Provisions

POSB223 Impact of the COVID-19 Pandemic on Influenza Vaccination Policies

PIN45 The Challenges of Estimating the Comprehensive Dengue Economic Burden

Cost-Effectiveness Analysis of a Vaccination Programme for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia in Adults Aged 50 and Over in Germany

RWD111 Influenza Vaccine Sales During the COVID-19 Era

EPH185 Increased Influenza Vaccine Coverage Rate Following COVID-19: Durable Trend or Epiphenomenon?

HPR202 Use of Real-World Data in Regulatory and Reimbursement Submissions for Personalized Medicines in Europe

HTA205 Time to Reimbursement Decisions for Personalized Medicines in the UK and France

POSC198 Impact of COVID-19 on Influenza Vaccine Coverage Rate During the 2020/2021 Season

POSB192 Public Health and Economic Impact of Influenza Immunization by Pharmacists: A Systematic Literature Review and Analysis of the French Experience

PIN56 Economic Value of Telaprevir for the Treatment of Previously Untreated F2 Fibrosis Chronic Hepatitis C Patients

PIN4 Mixed-Treatment Comparison of the Efficacy and Safety of Antiretroviral Drugs Indicated for Treatment-Experienced HIV Patients

1088 IMPACT OF SUSTAINED VIROLOGICAL RESPONSE (SVR) ON LIFE EXPECTANCY AND QUALITY-ADJUSTED LIFE-YEARS (QALYS) IN CHRONIC HEPATITIS C (CHC) PATIENTS

9081 POSTER Network Meta-analysis of Second and Third-line Treatments on Overall Response and Overall Survival in Patients With Metastatic Non-small Cell Lung Cancer

PIN79 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Population

PIN107 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Elderly Population

Suchergebnisse filtern